Doherty’s responsibilities will include oversight of clinical and non-clinical development, chemistry, manufacturing & controls and regulatory functions.
Gao has more than 25 years of experience in leading various functions including finance, audit, investment, project management, compliance and board office.
ExoXpert will operate the ExoPulse platform to serve demand from exosome developers for R&D-grade exosome vials as well as GMP manufacturing capabilities.
Singapore advanced therapy drug manufacturer secures $21mn growth capital funding to expand global genetic medicines design and manufacturing operations.